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Abstract.  Human neutrophils (PMN) express a het- 
erodimeric receptor that has ligand binding specificity 
for the Arg-Gly-Asp  (RGD)  sequence within many 
adhesive proteins. A monoclonal antibody, B6H12, 
which binds to this receptor,  inhibits both RGD- 
mediated ligand binding and stimulation of IgG- 
mediated phagocytosis by fibronectin, fibrinogen, 
vitronectin, yon Willebrand's factor,  and collagen type 
IV.  By several  criteria this receptor is neither a known 
very late antigen, a known cytoadhesin (gp IIb/IIIa- 
vitronectin receptor), nor a member of the LFA-1, 
Mac-l, p150,95 group of integrin receptors.  Ligand 
binding via this receptor is rapidly inactivated by 
products of the myeloperoxidase-hydrogen peroxide- 
halide system of PMN. We conclude that this receptor, 
for which we propose the name leukocyte response 
integrin, is a signal-transducing molecule on PMN 
which may have a significant early role in modulation 
of PMN function at inflammatory sites. 
T 
HE integrin superfamily of  adhesive receptors are trans- 
membrane heterodimeric molecules which function in 
cell-matrix  and  cell-cell  adhesion  (Hynes,  1987). 
They are thought to function in adhesion processes by serving 
as  transmembrane links between the extracellular environ- 
ment and the cytoskeleton  (Ruoslahti  and Pierschbacher, 1987; 
Buck,  1987). As such they are intimately involved in many 
complex  cell processes  including thrombosis,  hemostasis, 
cell  maturation,  embryogenesis,  lymphocyte  killing,  and 
phagocytosis. The integrins can be roughly classified into 
three groups:  (a)  the very  late antigens (VLAs) ~ first de- 
scribed  on T  lymphocytes,  including the fibronectin  (Fn) 
receptor from human placenta and osteosarcoma cells (Hem- 
ler et al., 1987); (b) cytoadhesins, including the platelet gp 
IIb/IIIa and the vitronectin receptor (VnR) (Ginsberg et al., 
1988); and  (c)  LFA-1, Mac-l,  p150,95, leukocyte-specific 
adhesion receptors,  including the complement receptor for 
C3bi (CR3) (Anderson and Springer,  1987). The heterodi- 
mers in each group are comprised of distinct alpha chains 
noncovalently linked to a common beta chain.  Because of 
this, monoclonal antibodies to the beta chain of each group 
can be used to classify new receptors as members of one or 
another group within the integrins. As an example, the Fn 
receptor was shown to be a member of the VLA group be- 
1. Abbreviations used in this paper:  CBD,  cell-binding domain; cc, cyto- 
chrome c; E, sheep erythrocytes;  Fg, fibrinogen; Fn, fibronectin; LAD, leu- 
kocyte adhesion deficiency; MPO, myeloperoxidase;  PI, phagocytic index; 
PMN, human neutrophils; PRBP, placental  RGD-binding proteins; VLA, 
very late antigens; Vn, vitronectin; VnR,  vitronectin receptor;  vWE yon 
Willebrand's factor. 
cause it bound A-1A5, a monoclonal antibody which recog- 
nizes all VLA beta chains. 
In addition to significant structural and sequence homol- 
ogy, the  integrins  also  exhibit ligand-binding  similarities. 
Several of these receptors were first discovered because of 
their binding to extracellular matrix proteins via an Arg-Gly- 
Asp (RGD) sequence in the matrix ligands. Our laboratory 
has recently characterized the RGD-binding proteins of hu- 
man neutrophils (PMN) and monocytes by affinity chroma- 
tography  of cell  lysates  on  RGD-Sepharose  (Brown and 
Goodwin,  1988). We showed that both phagocytes express 
a heterodimeric  receptor  distinct  from the  LFA-1, Mac-l, 
p150,95  family which  exhibits  immunological  cross-reac- 
tivity with gp IIb/IIIa  on platelets.  Phagocytes undergo a 
number of important functional changes during recruitment 
to an inflammatory or infected site. These include changes 
in the receptors expressed at the plasma membrane, activa- 
tion of new metabolic pathways, increases  in oxygen con- 
sumption and the production of reactive oxygen metabolites, 
and augmentation of phagocytosis. Extracellular matrix pro- 
teins have been shown to mediate some of these physiologic 
changes, especially enhancement of ingestion of opsonized 
particles by monocytes and macrophages. This enhancement 
is dependent  on recognition of the RGD sequence  within 
these matrix proteins (Brown and Goodwin,  1988; Wright 
and Meyer, 1985). We hypothesized that the molecule iden- 
tified by affinity chromatography on RGD-Sepharose might 
be the phagocyte receptor involved in extracellular matrix- 
stimulated ingestion. 
Here we report the definitive identification of the phago- 
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polyclonal  and monoclonal  antibodies  which inhibit  both 
RGD-dependent  ligand  binding  and extracellular  matrix- 
stimulated ingestion by human PMN. The monoclonal anti- 
body B6H12, which inhibits  RGD-mediated  phagocytosis 
enhancement, recognizes an antigen on PMN that is distinct 
from any other previously described integrin and has a broad 
specificity for RGD-containing proteins. Interestingly, ligand 
binding by this receptor is rapidly lost upon activation of the 
myeloperoxidase (MPO)-H202-halide  system in PMN, per- 
haps suggesting that this receptor is important early in the 
inflammatory response of PMN, before significant respira- 
tory burst or degranulation  occur. 
Materials and Methods 
Special Reagen  ts 
The  following reagents were purchased from Sigma Chemical Co.  (St. 
Louis,  MO):  chicken egg albumin  (ovalbumin),  eatalase (bovine liver; 
52,000 U/mg), cytochrome c (cc) (type XIV; pigeon heart), and fibrinogen 
(Fg). A  10-fold concentrated stock of Hank's balanced salt solution (HBSS) 
was  purchased  from  Gibeo  Laboratories  (Grand  Island,  NY).  Human 
vitronectin (Vn) was purchased from Calbiochem-Behring Corp. (La Jolla, 
CA). Human fibronectin and the chymotryptic cell-binding domain (CBD) 
of 105-110 kD were purified as described (Bohnsack et al., 1986). Collagen 
type IV and laminin were kind gifts of Dr. Hynda Kleinmann, National In- 
stitute of Dental Research, Bethesda, MD; yon Willebrand's Factor (vWF) 
was the kind gift of Dr.  Sam Santoro, Washington University, St.  Louis, 
MO. The synthetic peptides GRGDSC and GDGDSC were prepared by the 
Peptide Chemistry Facility, Washington University School of Medicine, and 
KYAVTGRGDS was the gift of Dr.  Steven Adams, Monsanto Corp., St. 
Louis, MO. GRGDSC, GDGDSC, or C as a control was linked to cc via 
bromacetyl succinamide (Bernatowicz and Matsueda, 1986). The molar ra- 
tio of incorporation of peptides or cysteine to cc was ",,8:1, as determined 
by titration of free sulfhydryls with 5,5-dithio-bis-(2-nitrobenzoic  acid). 
Purification of  RGD-binding Proteins  from 
Human Placenta 
Membranes were isolated from fresh human placenta, processed, and solu- 
bilized exactly as described (Calderon et al., 1988).  Protein was incubated 
with wheat germ agglutinin, and adherent proteins were eluted with 0.5 M 
N-acetylglucosamine (GIcNAc) in a  0.5  M  NaCI,  0.05  M  PO4,  pH 7.4, 
buffer containing PMSF, iodoacetamide, and 50 mM octyl glucoside. The 
eluate was dialyzed to remove the GIcNAc and applied to an -IFN-Sepha- 
rose column. Unbound protein was washed through with octylglucoside- 
containing buffer and applied to a column beating KYAVTGRGDS. Bound 
proteins were eluted by EDTA (Brown and Goodwin, 1988).  SDS-PAGE 
analysis showed only two Coomassie-stained bands which had relative mo- 
lecular masses on both unreduced and reduced gels consistent  with the VnR. 
Since this protein pool contained more than one protein (see below) we have 
called it the placental RGD-binding proteins (PRBP). 
Monoclonal and Polyclonal  Antibodies 
mAb A1A5 tissue culture supernatant was the gift of Dr.  Martin Hemler, 
Dana Farber Cancer Center, Harvard Medical School, Boston, MA. Goat 
polyclonal anti-Fn receptor (VLA-5) was the gift of Dr. Rudolph Juliano, 
University of North Carolina,  Chapel Hill,  NC.  Polyclonal antibody to 
PRBP was produced in rabbits. The IgG was isolated from serum by ca- 
prylic acid precipitation and DEAE chromatography (Steinbuch and Au- 
dran, 1969). Fab fragments were prepared by papain digestion. Monoclonal 
antibodies were produced by immunization of BALB/c mice with purified 
PRBP.  Spleen cells were fused with the nonsecreting myeloma cell line 
P3X63AG8.6.5.3.  Hybridoma culture supernatants were screened for anti- 
bodies that reacted with purified PRBP by ELISA. Reactive antibodies were 
screened further for binding to PMN by indirect immunofluorescent stain- 
ing and fluorescence flow cytometry. Antibodies 7(32, B3F12,  6H12, and 
3F12 were reactive with purified PRBP by ELISA but unreactive with PMN. 
These mAbs also immunoprecipitated VnR from detergent-solubilized pla- 
cental membrane preparations. The identity of the immunoprecipitated ma- 
terial as authentic VnR was confirmed by limited NH2-terminal sequencing 
of the alpha chain, mAb 7(32 reacted with the VnR beta chain by Western 
blot; none of the others reacted on Western blots, suggesting that they recog- 
nized conformational epitopes on VnR. mAb B6HI2 was reactive both with 
purified PRBP by ELISA and with PMN by fluorescence flow cytometry. 
Antibodies were produced in the form of tissue culture supernatants or as- 
cites in pristane-primed mice for further characterization. IgG was purified 
from ascites by caprylic acid precipitation and  DEAE  chromatography 
(Steinbuch and Audran,  1969). 
Isolation of PMN 
PMN were isolated from heparinized blood from normal volunteers and 
from a  single patient with leukocyte adhesion deficiency (LAD) by the 
method of Boyum (1968)  with modifications (Gresham et al.,  1987).  In 
some experiments the erythrocyte lysis step was omitted to prevent possible 
damage to the PMN during the hypotonic lysis procedure. 
Immunoprecipitation and SDS-PAGE  Analysis 
For cell surface labeling, 30-100  ×  106 PMN were iodinated by chloro- 
glycoluril (Markwell and Fox, 1978) in the presence of  25 #M paranitrophe- 
nylparaguanidinobenzoate and 0.5% NaN3  for 30 rain at 0°C. Ceils were 
solubilized in Hepes buffer containing 200 mM octylglucoside, 20 mM 
iodoacetamine, 2 #M pepstatin, 2 p.M leupeptin, 25/.tM paranitrophenyl- 
paraguanidinobenzoate,  1 mM CaCI2,  and  1 mM MgCI2,  pH 7.4.  Total 
placental membrane proteins were labeled with 125I using chloroglycoluril 
after detergent solubilization. Protein-bound and free iodide were separated 
on Sephadex G-25 columns. Aliquots of labeled proteins were incubated 
with monoclonal or polyclonal antibodies for 2  h at 4°C and then for an 
additional hour with either anti-mouse Ig Sepharose (Cooper Biomedical, 
Inc., Malvern, PA) or Protein A-Sepharose (Pharmacia Fine Chemicals, 
Piscataway,  NJ),  respectively. Immunoprecipitates were analyzed on 6% 
SDS-polyacrylarnide gels, and autoradiography  was performed as described 
(Maizel,  1971). 
Opsonization of Sheep Erythrocytes 
Sheep erythrocytes (E) were purchased from Whittaker M.A. Bioproducts 
(Walkersville,  MD).  EIgG were prepared as described (Gresham et al., 
1987) using a 1:500 dilution of rabbit IgG anti-E (Diamedix, Miami, FL). 
Phagocytosis  Assay 
PMN  phagocytosis  was  assessed by  a  fluid-phase  assay  as  described 
(Gresham et al.,  1987, 1988).  PMN were suspended in HBSS containing 
4.2 mM NaHCO3,  10 mM Hepes, 1.5 mM CaCI2,  1.5 mM MgCI2, and 1% 
ovalbumin, pH 7.4 (HBSS++-I%  ovalbumin). The reaction mixtures con- 
rained  1.0  ×  105 PMN, the indicated antibody concentrations, the indi- 
cated stimulatory ligands, 5,000  U/ml catalase, and 15 #1 of EIgG (5.0  x 
105/ml) in a final volume of 115/tl. The assay tubes were incubated at 37°C 
in 5% CO2 for 30 min. The noningested E were lysed with 0.83%  ammo- 
nium chloride. Phagocytosis was assessed by light microscopy and quanti- 
tated as a phagocytic index (PI), the number of EIgG ingested/100  PMN. 
cc-RGDS Binding Assay 
cc-RGDS was radioiodinated by chloroglycoluril (Markwell and Fox, 1978) 
for 15 min at 0°C. PMN (5.0  x  105) in HBSS++-I%  ovalbumin were in- 
cubated with 10 p,g of radiolabeled cc-RGDS in the presence of 5,000 U/ml 
of catalase and 293/xg of unlabeled cc-C in a final volume of 250 #1. The 
reaction mixtures were incubated in 1.5 ml eppendorf tubes for 30 rain at 
37°C.  The mixtures were overlayered on Versilube (General Electric Co., 
Wilmington, MA) and centrifuged at  12,000 g to assess pellet-associated 
radioactivity.  Specific binding was determined by subtracting the radioactiv- 
ity bound in the presence of 293 ttg of unlabeled cc-RGDS from the total 
radioactivity bound in the absence of cold cc-RGDS. Unlabeled cc-C was 
included  in  the reaction to control  for any  binding due  to  cc  and  not 
specifically due to the RGDS peptide. For inhibition experiments, inhibitors 
were included during the entire incubation at the indicated concentrations. 
Antibodies were incubated with the PMN at the indicated concentrations 
for 15 min at room temperature before the addition of the other reactants. 
Fluorescence Flow Cytometry 
PMN (106) were stained with excess routine mAbs and FITC F(ab'): anti- 
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cells  were resuspended in 0.3  ml 0.5%  paraformaldehyde  in PBS  before 
analysis on a FACS IV (Becton  Dickinson & Co.,  Sunnyvale,  CA). 
Results 
Catalase Is Required to Demonstrate Both 
cc-RGDS Binding and Stimulation of  PMN Fc 
Receptor-mediated Phagocytosis 
Our previous data indicated  that while monocytes express 
both an integrin which binds to RGD-Sepharose and a struc- 
turally distinct integrin which binds preferentially to Sepha- 
rose bearing the Fn CBD, this is not the case for PMN. In- 
stead,  PMN  express a  single  integrin-like  receptor which 
binds preferentially to RGD-Sepharose columns (Brown and 
Goodwin,  1988).  Because this presented a  simpler system 
for  determination  of  the  characterizations  of  the  RGD- 
binding receptor involved in phagocytosis enhancement, we 
chose to investigate extracellular matrix stimulation of PMN 
phagocytosis. Fn has been reported to stimulate ingestion of 
C3b-opsonized E by fMLF- or C5a-stimulated PMN (Pom- 
mier et al., 1984a), but not to stimulate the ingestion of EIgG 
by PMN  (Wright  et al.,  1983a).  We  wanted  to avoid the 
added  complication of chemotactic peptide  stimulation  of 
PMN,  as the expression of other adhesive receptors (i.e., 
CR3) which bind ligand via an RGD sequence (Wright et al., 
1987)  is markedly enhanced by these stimuli. We therefore 
decided to investigate further the ability of extracellular ma- 
trix  proteins  to  stimulate  EIgG  ingestion.  Because  many 
adhesive receptors are present on PMN, and matrix proteins 
such as Fn may interact with cell surfaces via several do- 
mains, we developed a nonphysiologic ligand which would 
interact with PMN only by an RGD sequence. We linked ei- 
ther  the  hexapeptide  GRGDSC,  GDGDSC,  or  the  single 
amino acid C as controls to pigeon heart cc via a bromacetyl 
succinamide linkage. The amino acid sequence for this cyto- 
chrome has been determined and does not contain an RGD 
sequence.  These  ligands  are  referred to as  cc-RGDS,  cc- 
DGDS, or cc-C and were used to assess RGDS-stimulated 
PMN Fc receptor-mediated phagocytosis. As shown in Fig. 
1 A, in the presence of catalase, cc-RGDS stimulated PMN 
ingestion of EIgG in a dose-dependent manner with an op- 
timal concentration of 40/~g/ml. As with other stimuli that 
affect PMN  Fc  receptor-mediated  ingestion,  the dose-re- 
sponse curve is biphasic (Gresham et al., 1987). This clearly 
distinguishes  the  dose-response  of RGDS  stimulation  on 
PMN  from that on monocytes (Pommier et al.,  1983).  In 
preliminary experiments we discovered that the inclusion of 
catalase was necessary to consistently observe cc-RGDS- 
stimulated ingestion (Fig.  1 A). Ingestion performed in the 
presence  of catalase  incubated  at  100°C  for  10  min  was 
significantly reduced (Fig. 1 A). cc-C or cc-DGDS up to con- 
centrations of 320 ttg/ml had no effect on EIgG ingestion 
even in the presence of catalase (data not shown). The effect 
of catalase on cc-RGDS-stimulated ingestion was dose-de- 
pendent (Fig. 1 B). The inclusion ofcatalase also slightly en- 
hanced  nonstimulated  ingestion of EIgG (Fig.  1 B).  This 
effect of catalase and  inhibitors  of the  MPO-H202-halide 
system on PMN IgG Fc- and complement-mediated inges- 
tion has been reported (Stendahl et al.,  1984; Gaither et al., 
1987). In addition, the inclusion of either 10 mM NaN3 (an 
inhibitor of MPO) or 10 mM methionine (a competitor for 
300 
PI  200 
•  •  Oatalaee 
./  \  •  100°C  /  \o--. 
I  • 
I°° r  I  I  I  I  I 
20  40  60  80 
,ug  cc-RGDS/ml 
•  40  /~gl~ c¢-RGDS  • 
• Buffer  •/•~ 
/ 
/ 
I  I  I  I 
1K  2K  3K  4K 
Units  Catnlaselml 
Figure 1.  Effect of catalase on cc-RGDS-stimulated  ingestion of 
EIgG. (A) PMN and EIgG were incubated with the final concentra- 
tions of cc-RGDS (20, 40, 60, or 80/zg/ml) in the presence of either 
5,000 U/ml of native catalase (A) or catalase heated at 100°C for 
10 min (e). After 30 min at 37°C, phagocytosis was assessed as 
a PI, the number of EIgG ingested/100 PMN. (B) PMN and EIgG 
were incubated with increasing concentrations  of catalase  in the 
presence (A) or absence (¢) of 40 #g/ml of cc-RGDS.  After 30 
min at 37°C, phagocytosis was assessed as a PI. 
the damaging oxidant) also revealed consistent stimulation of 
ingestion by cc-RGDS. These data indicated that the MPO- 
H202-halide system was generating an oxidant which dam- 
aged either some step in the pathway for RGD-mediated en- 
hancement of phagocytosis or the receptor responsible for 
cc-RGDS-stimulated ingestion. To examine the latter possi- 
bility, we examined the effect of catalase on the binding of 
radiolabeled cc-RGDS to PMN under the conditions of the 
phagocytosis assay. In the presence of catalase, a ninefold in- 
crease in the amount of cc-RGDS specifically bound was ob- 
served over the amount bound in the absence of catalase (Ta- 
ble I). These data indicated that at least one effect of catalase 
was  on  the  binding  of the  cc-RGDS  ligand.  To  examine 
whether catalase also protected some step in the process of 
RGD-stimulated ingestion, we assessed the effect of catalase 
on EIgG ingestion by PMN adherent to solid-phase Vn. In 
this assay the catalase was present only during the adherence 
of the PMN and was washed away before the addition of the 
EIgG. Vn contains an RGDS sequence and enhances mono- 
cyte ingestion  of EC3b  (Brown and  Goodwin,  1988).  As 
shown in Fig. 2, even though catalase was present only dur- 
ing the adherence of the PMN to either the control or the Vn- 
coated surface,  it significantly enhanced Vn-stimulated in- 
gestion of EIgG. These data and those in Table I indicated 
that the effect of catalase is on the interaction of the ligand 
with the PMN surface and not a general one on the phago- 
cytic process. All subsequent assays were performed in the 
presence of catalase. 
Table I. Effect of Catalase on cc-RGDS Binding 
Catalase  RGDS-specific cpm bound/106 PMN 
+  30,267  +  1,930  SEM,  n  =  10 
-  3,394  +  931  SEM,  n  =  5 
106 PMN were incubated with 40/zg of =25I--cc-RGDS in the presence (+) or 
absence (-) of 5,000  U of catalase/ml  for 30 min at 37°C.  The PMN were 
centrifuged through oil and the pellet-associated counts assessed. Specific bind- 
ing was calculated as described in Materials and Methods. 
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ingestion  of EIgG by  PMN 
adherent to control or V-coat- 
ed surfaces.  Plastic  Lab-Tek 
chambers  were  coated  with 
either  carbonate  buffer,  pH 
9.6 (Control), or 10 ~tg/ml of 
Vn  in carbonate  buffer  (Vn) 
for 2 h at 37°C. After wash- 
ing the chambers, PMN (2.5 
x  llY/well) were adhered in 
the  presence  or  absence  of 
5,000  U/ml  catalase  for 45 
min at 37°C. Catalase was re- 
moved by extensive washing. 
The  EIgG  were  added  and 
phagocytosis  assessed  after 
30 min at 37°C. 
mAb B6H12 and Polyclonal Fab Anti-PRBP 
Inhibit Both cc-RGDS Binding and 
RGD-stimulated Phagocytosis 
To facilitate isolation of the extracellular matrix receptor in- 
volved in phagocytosis enhancement,  we prepared a  poly- 
clonal (rabbit) and several monoclonal antibodies to human 
PRBP isolated from placenta.  The polyclonal and a  single 
monoclonal antibody, B6H12, bound to PMN as assessed by 
fluorescence flow cytometry analysis. We tested the effects of 
these antibodies on cc-RGDS-stimulated ingestion. As shown 
in  Fig.  3,  A  and B,  both  antibodies  inhibited  cc-RGDS- 
stimulated ingestion in a dose-dependent manner with com- 
plete inhibition at ~30 nM (B6H12) and 80 nM (Fab anti- 
PRBP). This dose of either antibody had no effect on EIgG 
ingestion by buffer-treated PMN (Fig. 3, A and B); however, 
at concentrations of >/16 tzg/ml, treatment of PMN with ei- 
ther  antibody  significantly  stimulated ingestion  in  the  ab- 
sence of cc-RGDS. The PI for PMN incubated with 100 nM 
B6H12 was 334, and for PMN incubated with 320 nM Fab 
anti-PRBP was 309. These values were very similar to those 
obtained with cc-RGDS stimulation in the same experiment 
(PI =  330 and 332,  respectively). Three other monoclonal 
antibodies made to the PRBP (B3F12, 6H12, and 3F12) did 
not bind to PMN and did not have any effect on either cc- 
RGDS-stimulated or nonstimulated ingestion of EIgG. All 
these antibodies immunoprecipitated VnR from placenta (de- 
termined by NH2-terminal sequencing  of the  immunopre- 
cipitated alpha chain) and stained endothelial cells (data not 
shown).  We also tested an antibody to the VnR beta chain, 
mAb 7G2 (Brown and Goodwin, 1988), which binds to plate- 
lets and can immunoprecipitate VnR from placenta and gp 
IIb/IIIa  from platelets. This mAb also did not bind to PMN 
and did not affect either cc-RGDS-stimulated or nonstimu- 
lated ingestion by PMN.  PMI-1, an anti IIb mAb (Ginsberg 
et al.,  1986), also does not bind to PMN (Brown and Good- 
win, 1988). Immunoprecipitation with B6H12 was unable to 
remove VnR  from placental  membrane extracts,  as  deter- 
mined by subsequent immunoprecipitation with 3F12 or 7G2 
(data not shown). In addition, neither polyclonal antibody to 
the Fn receptor (anti-VLA-5) (Brown and Juliano, 1986) nor 
mAb A-1A5 (anti-VLA beta chain) (Hemler et al., 1987) had 
any effect on either cc-RGDS-stimulated or nonstimulated 
ingestion of EIgG. The effect of mAb B6H12 and Fab anti- 
VnR was specific for cc-RGDS-stimulated phagocytosis be- 
cause  neither  antibody  had  any  effect on  EIgG ingestion 
stimulated  by phorbol  ester  treatment  of PMN  (data  not 
shown).  These data suggest that B6H12 recognizes an anti- 
gen which, while it binds to the RGD sequence, is not VnR, 
gp IIb/IIIa or a VLA. 
To  assess  whether  B6H12  or  Fab  anti-PRBP  prevented 
phagocytosis enhancement by inhibiting ligand binding, we 
examined the binding of radiolabeled cc-RGDS to antibody- 
treated PMN.  As shown in Table II, mAb B6H12 and Fab 
anti-PRBP  reduced  cc-RGDS binding  by 93.8  and 95.7%, 
respectively.  In  contrast,  mAb  B3F12  reduced  cc-RGDS 
binding only by 7.4%.  These data indicated that the poly- 
clonal  and  the  monoclonal  antibody  B6H12  inhibit  cc- 
RGDS-stimulated phagocytosis because they inhibit binding 
of the cc-RGDS ligand to the cell surface. 
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Figure 3. Effect of mAb B6H12 and polyclonal Fab anti-VnR on 
cc-RGDS-stimulated  ingestion  of EIgG.  PMN  were  incubated 
with the indicated concentrations of either mAb B6HI2 (A) or Fab 
polyclonal anti-VnR (B) for 15 min at room temperature.  Without 
washing, the EIgG were added and the mixture incubated with (&) 
or without  (e) 40 /,g/ml  of cc-RGDS.  After 30 min at 37°C, 
phagocytosis  was assessed as a PI. 
Table II. Inhibition of  cc-RGDS-specific  Binding to PMN 
Inhibitors  cc-RGDS specific cpm/10 6 PMN*  Inhibition* 
% 
cc-C  (1.16  mg/ml)  30,173  +  1,748  SEM,  n  =  11  0 
GRGDSC 
(500/~g/ml)  6,144  +  2,905  SEM,  n  =  3  79.6 
Peptide  32 
(500 ~g/ml)  39,442  +  7,800 SEM, n  =  2  0 
Fn (500 t~g/ml)  7,106  4-  3,568  SEM,  n  =  3  76.5 
Fat) anti-VnR 
(4/zg/ml)  1,312  +  867  SEM,  n  =  5  95.7 
B6H12  (4/~g/ml)  1,877  4-  1,811  SEM,  n  =  3  93.8 
B3FI2 (4/zg/rnl)  27,948  4-  5,701  SEM,  n  =  3  7.4 
* l06  PMN  were  incubated with 40  #g of ~25I-cc-RGDS with the  indicated 
concentrations of unlabeled inhibitors in the presence of 5,000  U catalase/ml 
for 30 rain at 37°C.  The PMN were centrifuged through oil and the pellet- 
associated counts  assessed.  Specific binding  was calculated  as described  in 
Materials and Methods. 
* Calculated  from the mean cpm.  Percent  inhibition  =  100  x  (1  -  [mean 
cpm in the presence of inhihitor]/[mean cpm in the presence of cc-C]). 
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Distinct from Previously Described Members of the 
lntegrin Receptor Family 
To ascertain the structure of the receptor recognized by the 
Fab anti-VnR  and mAb B6H12 and compare it to the struc- 
ture of the receptor isolated by RGD affinity chromatography 
(Brown and Goodwin, 1988), we surface labeled PMN and 
immunoprecipitated with the polyclonal anti-PRBP and sev- 
eral of the monoclonal antibodies produced against purified 
PRBP from placenta. Both the polyclonal antibody and mAb 
B6H12 immunoprecipitate a heterodimer of 130-140 kD and 
ll0 kD upon reduction (Fig. 4, lanes 2 and 4). Neither mAb 
7G2 (anti-gp IIb/IIIa) nor mAb B3F12 (anti-VnR)  immuno- 
precipitated any detectable proteins from PMN.  However, 
both mAb 7G2 and mAb B3F12 but not mAb B6H12 immu- 
noprecipitated a heterodimer from iodinated placental mem- 
brane proteins of 130 and 100 kD upon reduction (data not 
shown). To further distinguish the B6H12 antigen from the 
gp Ilb/IIIa antigen, surface-labeled platelets were immuno- 
precipitated with mAb 7G2 and the precipitate was compared 
under nonreducing conditions to the mAb B6H12 immuno- 
precipitate from PMN (Fig. 5, lanes 2 and 3). As is apparent, 
these two antibodies immunoprecipitate heterodimers with 
completely distinct alpha and beta chain relative molecular 
masses.  The PMN heterodimer cannot be immunoprecipi- 
tated with an antibody that recognizes the beta chain of the 
gp IIb/IIIa-VnR family (mab 7G2) and is therefore distinct 
from these cytoadhesins. 
We next investigated the possibility that the B6H12 antigen 
was a member of the LFA-1, Mac-l, p150,95  family of cell 
adhesion receptors. As shown in Fig. 6, mAb B6H12 binds 
normally to PMN from a patient with LAD (Anderson and 
Springer,  1987) as assessed by FACS analysis. This patient 
has been found previously (Kishimoto et al.,  1987) to lack 
expression of all members of this  family, and in our own 
studies  PMN  from this  patient failed to express any beta 
chain antigen as assessed by FACS analysis using antibody 
to the beta chain, mAb IB4 (Wright et al.,  1983b) (data not 
shown). In addition, binding of radiolabeled cc-RGDS was 
assessed  on  both  normal  and  LAD  PMN;  normal  PMN 
bound 11,978 RGDS-specific cpm/106 PMN while the LAD 
PMN bound  12,616  RGDS-specific cpm/106  PMN.  More- 
over, our previous work indicated that treatment of PMN ly- 
sates  with mAb  IIM did not immunoprecipitate the PMN 
receptor which bound to RGD-Sepharose (Brown and Good- 
win,  1988). These data indicated that the B6H12 antigen is 
not a member of the LFA-1, Mac-l, p150,95  family of cell 
adhesion receptors. Finally, we immunoprecipitated antigens 
recognized by polyclonal anti-VLA-5 from surface-labeled 
PMN.  Two bands at  "~160 and  130 kD were seen on au- 
toradiograms of gels run on reduced samples. These bands 
Figure 4.  Immunoprecipitation from surface-labeled PMN with 
mAb B6H12 or polyclonal anti-VnR. Surface-iodinated PMN ly- 
sates were immunoprecipitated with the following antibodies: (lane 
1) preimmune rabbit serum; (lane 2) rabbit polyclonal anti-VnR; 
(lane 3) mAb 7G2 (anti-VnR beta chain); (lane 4) mAb B6H12; 
and  (lane 5)  mAb B3F12  (anti-VnR).  The immunoprecipitates 
were analyzed under reducing conditions (50 mM DTT) by SDS- 
PAGE. 
Figure 5. Immunoprecipitation from surface-labeled platelets and 
PMN with mAb B6H12 and mAb 7G2. Surface-iodinated platelets 
(lanes I  and 2) and PMN (lanes 3-5)  were immunoprecipitated 
with the following antibodies: (lanes I and 3) mAb B6HI2; (lanes 
2 and 4) mAb 7G2; and (lane 5) mAb B3FI2. The precipitates 
were analyzed under nonreducing conditions by SDS-PAGE. 
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Figure 6. mAb B6HI2 profile of normal and LAD PMN as ana- 
lyzed by FACS.  Normal PMN (A) and LAD PMN (B) were ana- 
lyzed by indirect immunofluorescence for mAb B6H12. Both nor- 
mal and LAD PMN express the B6HI2 antigen.  LAD PMN are 
unable to express the Mac- 1, LFA- 1, p 150,95 because of  an abnor- 
mality in beta chain synthesis. 
did not align with the immunoprecipitates from anti-PRBP 
(data not shown), but are consistent with the reported mo- 
lecular masses of either VLA-2 or VLA-4 (Hemler et al., 
1987). Together with the data that neither AIA5 nor the poly- 
clonal anti-VLA-5 inhibit cc-RGDS-stimulated phagocytosis, 
these data suggest that the cell surface receptor recognized 
by B6H12 is not a VLA. In concert, these data demonstrate 
that the B6H12 antigen represents a previously unrecognized 
RGD-binding receptor. 
Many RGDS-containing Proteins Stimulate PMN Fc 
Receptor-Mediated Ingestion via a B6H12-dependent 
Mechanism 
Because cc-RGDS, but not cc-DGDS nor cc-C, was able to 
augment PMN phagocytosis of EIgG significantly, we con- 
cluded that the RGD(S) sequence was responsible for phago- 
cytosis enhancement.  This conclusion was substantiated by 
the fact that unlinked GRGDSC peptide inhibited specific cc- 
RGDS binding by 79.6% while an irrelevant peptide had no 
effect  (Table  II).  This  inhibition  was  not  limited  to  free 
RGDS peptide but could be demonstrated also by a protein 
containing an RGDS sequence, Fn, which inhibited specific 
cc-RGDS binding by 76.5%.  These data indicated that the 
mAb B6H12 recognized a  receptor which might recognize 
the RGD sequence of many proteins. 
Figure 7. Fn and its CBD stimulate ingestion of EIgG in a manner 
dependent on B6H 12 antigen. (A and B) PMN were incubated with 
5,000 U/ml catalase and a 1:120 dilution of tissue culture superna- 
tant containing either mAb B6H12 (e) or mAb B3F12 (A) for 15 
min at room temperature.  Without washing, the EIgG were added 
and the mixture  was incubated with either  increasing concentra- 
tions of Fn (A), increasing concentrations of its purified CBD (B), 
or 40 /zg/ml cc-RGDS  (open symbols). After 30 min  at 37°C, 
phagocytosis  was assessed.  (C) Fn (5 #g/ml) or buffer were in- 
cubated  with either  buffer,  or mAb Fn5,  Fn8,  or HFn7.1  at  10 
~g/ml for 30 min at room temperature.  PMN, 5,000 U/ml catalase, 
and EIgG were added and phagocytosis  assessed after 30 rnin at 
37°C. 
We examined the effect of Fn on PMN Fc receptor-medi- 
ated phagocytosis, and, as shown in Fig. 7 A, Fn stimulated 
ingestion  in  a  dose-dependent  manner.  As  with  cc-RGDS 
stimulation (Fig.  1 A), the dose-response curve was biphasic. 
Fn-mediated augmentation of ingestion was completely abro- 
gated by treatment of the  PMN with mAb B6H12  but not 
mAb B3F12.  However, nonstimulated or baseline levels of 
EIgG ingestion  were never affected by mAb B6H12  treat- 
ment. The CBD of Fn which contains the RGDS sequence 
also stimulated EIgG ingestion, though much less efficiently 
than the intact Fn molecule (Fig.  7 B).  This is in contrast 
to monocyte ingestion which is not augmented by the purified 
CBD fragment (Bohnsack et al., 1986; Brown and Goodwin, 
1988).  mAb B6H12 and not mAb B3FI2 completely abro- 
gated CBD-stimulated ingestion by PMN (Fig. 7 B). To fur- 
ther localize the region of the Fn molecule which was in- 
volved in phagocytosis enhancement, an optimal dose of Fn 
was  incubated  with  various  monoclonal  antibodies  which 
recognize distinct domains of Fn before stimulation of PMN. 
As  shown  in  Fig.  7  C,  neither  Fn8,  which  recognizes the 
NH2 terminus  of Fn,  nor Fn5,  which  recognizes a  site in 
the  CBD NH2  terminal to the  RGDS sequence  (Bohnsack 
et al.,  1986),  had any effect on Fn-stimulated ingestion of 
EIgG. However, HFn7.1, which recognizes a site close to the 
RGDS sequence in the CBD, completely abrogated Fn-stim- 
ulated phagocytosis. A similar effect of HFn7.1 has been ob- 
served for Fn-stimulated monocyte phagocytosis (Bohnsack 
et al.,  1986).  These data indicated that the CBD of the Fn 
molecule which contains the RGDS sequence was responsi- 
ble for augmentation of PMN Fc receptor-mediated inges- 
tion by intact Fn and that mAb B6H12 recognized the recep- 
tor which mediated this enhancement. 
We investigated other extracellular matrix proteins which 
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Figure 8. Effect of mAb B6H12 on collagen type IV- and laminin- 
stimulated ingestion of EIgG. (A and B) PMN and 5,000 U/ml of 
catalase were incubated with a 1:20 dilution of tissue culture super- 
natant containing either mAb B3F12 (*) or mAb B6HI2 (e) for 15 
rain at room temperature. Without washing, the EIgG were added 
and the mixture was incubated with either increasing concentra- 
tions of collagen type IV (A), increasing concentrations of laminin 
(B), or 40 #g/ml  of cc-RGDS (open symbols).  After 30 min at 
37°C, phagocytosis was assessed. 
have been reported to contain RGD sequences for their abil- 
ity to augment ingestion via the B6H12 antigen. As shown 
in Fig.  8, A and B, both collagen type IV and laminin en- 
hanced  PMN  Fc  receptor-mediated  ingestion;  however, 
mAb  B6H12  inhibited  only  collagen-stimulated  ingestion 
and not laminin-stimulated ingestion. Therefore, the B6H12 
antigen was not able to recognize an RGD sequence in all ex- 
tracellular matrix proteins. This is not surprising for lami- 
nin, because it has been shown to interact with nonintegrin 
receptors via domains  completely distinct from RGD  se- 
quence (Graf et al.,  1987). 
Because the B6H12 receptor appeared to recognize several 
proteins with RGD sequences, it appeared to function like 
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Figure 9. Effect ofmAb B6H12 on Vn-, vWF-, and Fg-stimulated 
ingestion of EIgG. (A-C) PMN and 5,000 U/ml catalase were in- 
cubated with a 1:20 dilution of tissue culture supernatant contain- 
ing mAb B3F12 (&) or mAb B6HI2 (e) for 15 rain at room tem- 
perature. Without washing, the EIgG were added and the mixture 
was incubated with either increasing concentrations of Vn (A), in- 
creasing concentrations of vWF (B), increasing concentrations of 
Fg (C), or 40 #g/ml of cc-RGDS (open symbols).  After 30 rain 
at 37°C,  phagocytosis was assessed. 
the gp IIb/IIIa receptor of platelets which binds Vn,  vWE 
and Fg, as well as Fn. We also investigated these proteins for 
augmentation of ingestion via the B6H12 antigen. As shown 
in Fig. 9, all three of these ligands stimulated PMN ingestion 
of EIgG in a dose-dependent manner. Moreover, the stimu- 
lated ingestion by all of these ligands was prevented by treat- 
ment of the PMN with mAb B6H12 but not mAb B3F12. 
These data indicated that the  B6H12  receptor recognized 
RGD sequences in many proteins and mediated phagocytosis 
stimulation by many, but not all, adhesive proteins. 
Discussion 
Data  from our laboratory indicate that  receptor-mediated 
phagocytosis by PMN is a recruited function at inflammatory 
sites (Gresham et al., 1988). In this regard, various integrins 
expressed on PMN may exert a significant regulatory influ- 
ence on PMN phagocytic function. Therefore, assessment of 
the structure, ligand-binding specificity, and mechanisms for 
regulation of these receptors is a primary goal of our labora- 
tory. To facilitate isolation of the RGD-binding receptors in- 
volved in regulation of phagocytic function, we have devel- 
oped an assay for the effects of various adhesive proteins on 
PMN phagocytosis. This assay allowed us to investigate the 
effect  of polyclonal and monoclonal antibodies which we and 
others produced against various integrin receptors. Two fac- 
tors led to the successful development of this assay: (a) the 
use of a nonphysiologic ligand, cc-RGDS, allowed us to ex- 
amine ligand binding as well as RGDS-stimulated ingestion 
without interference from other domains in adhesive pro- 
teins which may be involved in binding but which do not aug- 
ment phagocytosis (Pommier et al.,  1984b; Bohnsack et al., 
1986); and (b) the presence of catalase in the reaction mix- 
ture allowed us to observe RGDS-stimulated EIgG ingestion 
by PMN consistently. 
The protective effect of catalase indicated that an oxidant 
being generated during the incubation was  preventing cc- 
RGDS  augmentation  of Fc  receptor-mediated  ingestion. 
This fact probably explains the previously reported failure to 
detect Fn enhancement of PMN ingestion of EIgG (Wright 
et al.,  1983a).  Like catalase,  NaN3 and methionine could 
protect cc-RGDS stimulation, indicating that it is likely that 
the MPO-H~O2-halide system of PMN was  generating an 
oxidant (possibly HOCI) which prevented phagocytosis en- 
hancement.  This  system  has  been  shown  to  partially  in- 
hibit both IgG Fc- and complement-mediated ingestion by 
PMN (Stendahl et al., 1984; Gaither et al., 1987). As shown 
in Fig.  1 B and Fig.  2, the inclusion of catalase enhanced 
EIgG ingestion by buffer-treated PMN as reported (Stendahl 
et al.,  1984). However, the most marked effect of catalase 
was on RGD-stimulated ingestion, which was only minimally 
different from baseline ingestion in the absence of catalase. 
The inclusion of catalase in our assay also resulted in a nine- 
fold increase in ligand binding (Table I) and was necessary 
only during interaction with the ligand and not during inges- 
tion (Fig. 2). Therefore, we concluded that in our assay the 
primary effect of catalase is on the interaction of the RGD 
ligand with the PMN and not on a step in the phagocytic pro- 
cess. We suggest that the receptor involved in RGDS-stim- 
ulated phagocytosis is damaged by the generated oxidants, 
thus inhibiting ligand binding. Thus, the generation of oxi- 
dants at inflammatory sites may actually act to inhibit the 
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receptor acts very early in the PMN response to the inflam- 
matory stimulus, before significant release of MPO or activa- 
tion of the respiratory burst. 
Because  our previous work indicated  an  antigenic  and 
structural similarity of the PMN RGD-binding receptor to 
the  gp  IIb/IIIa-VnR  family,  we  prepared  polyclonal  and 
monoclonal antibodies to purified VnR and assessed their 
effect on cc-RGDS-stimulated  ingestion.  Both polyclonal 
anti-VnR and a single monoclonal antibody, B6H12, bound 
to PMN and inhibited both cc-RGDS binding and cc-RGDS- 
stimulated ingestion (Fig. 3; Table II). mAb B6H12 immuno- 
precipitated a heterodimeric receptor similar in molecular 
weight to the RGD-binding proteins detected by affinity chro- 
matography of lysates from surface-iodinated PMN (Brown 
and Goodwin, 1988). However, mAb B6H12 did not appear 
to recognize a member of the cytoadhesin family because a 
monoclonal antibody (mAb 7G2) that binds to the beta chain 
of the gp IIb/IIIa-VnR family had no effect in our assay and 
did not bind to PMN nor immunoprecipitate any surface- 
labeled proteins from PMN (Fig. 4). These data along with 
the failure of anti-lib mAb PMI-1  to bind to PMN (Brown 
and Goodwin, 1988) indicate that, unlike a previous report 
(Burns et al.,  1986), we cannot detect gp lib/Ilia on PMN. 
Three other mAbs,  which  recognized placental  VnR and 
VnR on both endothelial cells and fibroblasts (data not shown) 
also did not bind to nor immunoprecipitate any proteins from 
PMN, and had no effect on cc-RGDS-stimulated ingestion 
or binding (Table II). Moreover, mAb B6H12 recognizes a 
heterodimer on PMN which is distinct from either gp lib/ 
Ilia or placental VnR (Figs. 4 and 5). Since B6H12 clearly 
inhibited Fn-enhanced phagocytosis, the PMN integrin is not 
identical to the M21 membrane RGD receptor (Cherish and 
Spiro, 1987). These data demonstrate that this receptor is not 
a known cytoadhesin. Since the immunogen used to produce 
B6H12 consisted of all wheat germ agglutinin-binding pro- 
teins from placental membranes which also bound to RGD- 
Sepharose, it is likely that a small amount of B6H12 antigen 
was present in the placental PRBP preparation. 
Several lines of evidence indicate that the receptor recog- 
nized by mAb B6H12 is also not a member of the VLA or 
the  LFA-1, Mac-l,  p150,95  groups  of integrin  receptors. 
First, PMN from a patient with LAD which do not express 
the beta chain antigen of the LFA-1 group, do express B6H12 
antigen (Fig. 6) and bind radiolabeled cc-RGDS normally. 
Also monoclonal antibody to the beta chain of this group 
fails  to  remove the  RGD-binding  proteins  from  surface- 
labeled PMN (Brown and Goodwin, 1988). Second, mAb to 
the VLA beta chain (A-1A5) does not bind to granulocytes 
(Hemler et al., 1987). Although polyclonal anti-VLA-5 anti- 
body did bind to granulocytes, it immunoprecipitated an an- 
tigen or antigens  of different apparent relative molecular 
masses  than  that  immunoprecipitated by  B6H12  or  anti- 
PRBP. In addition neither mAb A-1A5 nor polyctonal anti- 
VLA-5 affected cc-RGDS-stimulated ingestion, mAb B6H12 
cannot recognize the VLA beta chain as it does not bind to 
fibroblasts (Brown, E. J., and John McDonald, unpublished 
observation). These data suggest that the receptor expressed 
on PMN recognized by mAb B6H12 is not previously de- 
scribed. Since it transduces the signal for increased phagocy- 
tosis, we propose the name leukocyte response integrin for 
this new receptor. While it may be an integrin from a new 
group, polyclonal anti-VnR and anti-gp IIb/IIIa both recog- 
nize it,  suggesting that B6H12 antigen is immunologically 
related to the cytoadhesins; thus, this antigen may represent 
a new alpha chain in combination with the cytoadhesin beta 
chain. Amino acid sequence analysis of the B6H12 antigen 
will be required to determine its relationship to the known 
groups of integrins. 
While this RGD-binding receptor on PMN involved in ex- 
tracellular matrix-stimulated ingestion is not gp lib/Ilia, it 
expresses a similar ligand binding specificity. Fn, Vn, vWF, 
and Fg all bound to the PMN receptor, because they en- 
hanced PMN phagocytosis in a B6H12-inhibitable manner. 
Unlike gp Iib/IIIa, the PMN phagocytosis-enhancing recep- 
tor recognized by B6H12 also bound collagen type IV. Lami- 
nin, an adhesive protein which contains an RGD sequence, 
also enhanced PMN ingestion but did so independently of 
the receptor recognized by mAb B6H12. This fact is consis- 
tent with the observation that laminin interacts with noninte- 
grin receptors via domains distinct from the RGD sequence 
(Graf et  al.,  1987).  The  fact that  mAb  B6H12  inhibited 
RGD-stimulated ingestion by a number of adhesive proteins 
does not rule out a role for other adhesive receptors function- 
ing in iigand binding. Fg has been reported to bind to CR3 
on PMN and monocytes (Altieri et al.,  1988), yet our data 
indicate that all Fg-stimulated ingestion is blocked by mAb 
B6H12. It may be, as we have hypothesized for Fn (Bohnsack 
et al., 1986; Brown and Goodwin, 1988), that other domains 
of these adhesives molecules are involved in ligand binding, 
but that for PMN at least, augmentation of ingestion is de- 
pendent on the RGD-sequence and is mediated by the recep- 
tor recognized by mAb B6H12. 
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